Novo Nordisk | NVO - 流動資産





流動資産 変化する 日付
ANI Pharmaceuticals USD 825.43M 78.35M 2026-06
Aurora Cannabis CAD 397.45M 48.38M 2026-03
Bausch Health Companies USD 6.52B 544M 2026-06
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Canopy Growth CAD 529.47M 4.8M 2026-03
Corcept Therapeutics USD 439.68M 13.64M 2026-06
Drreddys Laboratories INR 301.98B 298.66B 2026-03
Eli Lilly USD 64.67B 9.84B 2026-06
GlaxoSmithKline GBP 17.56B 202M 2026-06
Merck USD 36.68B 1.66B 2026-06
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Novartis USD 27.35B 744M 2026-06
Novo Nordisk DKK 208.7B 31.38B 2026-06
Novo Nordisk DKK 31.89B 145.42B 2026-06
Pacira USD 615.21M 100.25M 2026-06
Perrigo USD 2.45B 260.7M 2026-06
Phibro Animal Health USD 935.51M 41.44M 2026-06
Prestige Brands USD 496.81M 65.33M 2026-06
Sanofi EUR 31.52B 1.36B 2026-06
Supernus Pharmaceuticals USD 723.5M 8.08M 2026-06
Zoetis USD 6.36B 118M 2026-06